Denis Mulleman
Université de Tours(FR)Centre National de la Recherche Scientifique(FR)Centre Hospitalier Universitaire de Tours(FR)Centre de Biophysique Moléculaire(FR)Research & Diagnostic Antibodies (United States)(US)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, Infectious Diseases and Tuberculosis, Spondyloarthritis Studies and Treatments
Most-Cited Works
- → Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial(2014)469 cited
- → Pathophysiology of disk-related sciatica. I.—Evidence supporting a chemical component(2005)185 cited
- → Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial(2014)176 cited
- → Optimal Duration of Antibiotic Therapy in Vertebral Osteomyelitis(2007)172 cited
- → Rituximab‐Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response(2013)161 cited
- → Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases(2011)